| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/29/2011 | CN102106919A Method for controlling quality in extraction process of traditional Chinese medicine chuanhong blood circulation-activating capsules |
| 06/29/2011 | CN102106918A Method for simultaneously preparing volatile oil, total flavones and total alkaloids from immature bitter oranges |
| 06/29/2011 | CN102106914A Medicament for treating infectious diseases, preparation method and application thereof |
| 06/29/2011 | CN102106908A Chinese medicinal preparation for treating stroke |
| 06/29/2011 | CN102106904A Method for preparing pharmaceutical preparation for treating palpitation and cardiodynia and quality control method thereof |
| 06/29/2011 | CN102106896A New application of obscured homalomena rhizome (Chinese medicinal plant) in pharmacy |
| 06/29/2011 | CN102106895A Composition with function of regulating blood fat |
| 06/29/2011 | CN102106891A Cardio-cerebral refreshing sustained-release soft capsules and preparation method thereof |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106878A Preparation method of ginkgo leaf extract liquid-filling capsule |
| 06/29/2011 | CN102106877A Production process of gingko leaf extract |
| 06/29/2011 | CN102106867A Application of ophiopogon japonicus polysaccharide MDG-1 in preparation of medicament for promoting angiogenesis |
| 06/29/2011 | CN102106853A Chemical medicine composition for treating hypertension |
| 06/29/2011 | CN102106846A Levogyration esmolol hydrochloride medicinal compositions and preparation method thereof |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106817A Pre-emulsified propylgallate concentrate and preparation thereof |
| 06/29/2011 | CN102106816A Resveratrol nanometer preparation and preparation method thereof |
| 06/29/2011 | CN102106809A Solid preparation of clopidogrel and preparation method thereof |
| 06/29/2011 | CN102106587A Preparation method and application of extracts from natural plants |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |
| 06/29/2011 | CN102106417A Dandelion health-preservation tea |
| 06/29/2011 | CN101869692B Curcumin self-microemulsion and preparation method thereof |
| 06/29/2011 | CN101849985B Chinese medicament for treating tachycardia |
| 06/29/2011 | CN101843831B Chinese medicament for treating diabetic cardiopathy |
| 06/29/2011 | CN101843829B Chinese medicament for treating pulmonary heart diseases |
| 06/29/2011 | CN101843647B Chinese medicament for treating angina |
| 06/29/2011 | CN101843644B Chinese medicament for treating tachycardia |
| 06/29/2011 | CN101804183B Medicine for treating coronary heart disease |
| 06/29/2011 | CN101708290B Chinese medicinal preparation for treating viral myocarditis |
| 06/29/2011 | CN101708260B Chinese medicinal preparation for treating rheumatic heart valve disease |
| 06/29/2011 | CN101708237B Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof |
| 06/29/2011 | CN101693045B Effective portion of conical hydrangea, preparation method thereof, and composition and usage thereof |
| 06/29/2011 | CN101647781B Preparation method of ligustrazine phosphate powder injection |
| 06/29/2011 | CN101642483B Microwave treatment and storage method of snakegourd fruits |
| 06/29/2011 | CN101618059B Preparation method and medical application of cynoglossum zeylanicum total phenolic acid |
| 06/29/2011 | CN101591374B Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds |
| 06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 06/29/2011 | CN101579480B Medicinal dripping pill for treating hypertension |
| 06/29/2011 | CN101507738B Preparation method of Shu Xuening injection |
| 06/29/2011 | CN101491532B Erigeron breviscapus eye-preparation and preparation method thereof |
| 06/29/2011 | CN101361801B Qiancao Naomaitong medicine for treating apoplexy or the like and preparation method thereof |
| 06/29/2011 | CN101357198B Traditional Chinese medicine for treating cerebral thrombus |
| 06/29/2011 | CN101306183B Common turmeric extract fat emulsion injection and its preparation method and use |
| 06/29/2011 | CN101306181B Elemene fat emulsion injection and preparation method thereof |
| 06/29/2011 | CN101200443B Nitrogen heterocyclic methyl ethyl ketone derivatives, preparation method and medicine combination containing the same |
| 06/29/2011 | CN101181322B Composition of ligustrazine and acanthopanax senticosus extract as well as application in the preparation of anti-cardiovascular medicament thereof |
| 06/29/2011 | CN101048180B Solid formulation with improved solubility and stability, and method for producing said formulation |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968664 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
| 06/28/2011 | US7968596 Preparation and diabetic use of Gibberellins |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
| 06/28/2011 | US7968529 Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968126 Propagating mesenchymal stem cells into strip for use in treatment of heart defects; tissue engineering and repair; regenerative medicine |
| 06/28/2011 | CA2645291C Dibenzyl amine derivatives as cetp inhibitors |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2436342C Coated vascular filters |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
| 06/23/2011 | WO2011075596A1 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/23/2011 | WO2011074731A1 Peptide having a blood pressure-lowering ability |
| 06/23/2011 | WO2011074658A1 Novel anti-platelet agent |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | WO2011073165A1 New phenylhydrazone derivatives and their use as pharmaceuticals |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011073118A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
| 06/23/2011 | WO2011072619A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | WO2011072496A1 Epothilone compounds, preparation method and use thereof |
| 06/23/2011 | WO2011072484A1 Target and medicaments for treatment of brain injuries |
| 06/23/2011 | WO2011072483A1 Compositions and methods for controlling proliferation and differentiation cells |
| 06/23/2011 | WO2011072390A1 Compositions and methods related to mirna in diabetic conditions |
| 06/23/2011 | WO2011026606A3 Composition for the treatment of hemorrhoids and related diseases |
| 06/23/2011 | WO2011017554A3 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152835 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/23/2011 | US20110152371 Antioxidant extract from fruit skins |
| 06/23/2011 | US20110152361 Novel epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152331 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152327 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152316 3,4-substituted piperidine derivatives as renin inhibitors |
| 06/23/2011 | US20110152315 Compounds for the treatment of metabolic diseases |
| 06/23/2011 | US20110152295 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/23/2011 | US20110152294 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising osmolyte as active agent component |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152283 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152265 Carboxamide compounds and their use as calpain inhibitors v |